Nicolas Poirier
Company: OSE Immunotherapeutics
Job title: ceo
Seminars:
Roundtables: Exploring Novel Technologies From Discovery Through to the Clinic to Ensure Success of Your Molecule 4:30 pm
Using predictive computational models to identify treatment responders/non-responders Assessing drug properties and predict pharmacokinetics, optimize formulations Optimizing clinical trial design Leveraging artificial intelligence to enhance production and manufacturing of your moleculeRead more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day One
Revealing Cytomask®: Cis-Demasking Cytokine Technology for Targeted Delivery 2:00 pm
Outlining masking cytokine technology, allowing activity on-demand at the Right Site but suffers from enzyme selectivity Cis-delivery cytokine technology allows redirection of activity on the right cells but requires potent cytokine attenuation and non-optimal cell selectivity Cytomask® is a novel Cis-Demasking cytokine technology avoiding cytokine attenuation and lack of selectivity of cleavable linkers to unmask…Read more
day: Conference Day One
Chair’s Closing Remarks 5:30 pm
day: Conference Day One